S

StemRIM Inc
TSE:4599

Watchlist Manager
StemRIM Inc
TSE:4599
Watchlist
Price: 305 JPY Market Closed
Market Cap: 18.9B JPY
Have any thoughts about
StemRIM Inc?
Write Note

StemRIM Inc
Effect of Foreign Exchange Rates

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

StemRIM Inc
Effect of Foreign Exchange Rates Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Effect of Foreign Exchange Rates CAGR 3Y CAGR 5Y CAGR 10Y
S
StemRIM Inc
TSE:4599
Effect of Foreign Exchange Rates
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
GNI Group Ltd
TSE:2160
Effect of Foreign Exchange Rates
-ÂĄ869.7m
CAGR 3-Years
N/A
CAGR 5-Years
-38%
CAGR 10-Years
-42%
PeptiDream Inc
TSE:4587
Effect of Foreign Exchange Rates
-ÂĄ160.3m
CAGR 3-Years
N/A
CAGR 5-Years
-39%
CAGR 10-Years
N/A
Takara Bio Inc
TSE:4974
Effect of Foreign Exchange Rates
ÂĄ1.3B
CAGR 3-Years
33%
CAGR 5-Years
N/A
CAGR 10-Years
27%
Pharma Foods International Co Ltd
TSE:2929
Effect of Foreign Exchange Rates
ÂĄ5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-8%
C
Cuorips Inc
TSE:4894
Effect of Foreign Exchange Rates
ÂĄ1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

StemRIM Inc
Glance View

Market Cap
18.8B JPY
Industry
Biotechnology

StemRIM, Inc. engages in the research and development of regeneration inducing medicine. The company is headquartered in Ibaraki-Shi, Osaka-Fu and currently employs 46 full-time employees. The company went IPO on 2019-08-09. The firm is engaged in the development and research of medicines based on new action mechanism to promote functional regeneration and healing of biological tissue damaged and lost function due to injury or illness. The Company’s main product is stem cell regeneration-inducing medicine. The stem cell regeneration-inducing medicine is a medicine which can obtain the same therapeutic effect as regenerative medicine only by administering the medicine without using living cells and tissues.

Intrinsic Value
150.01 JPY
Overvaluation 51%
Intrinsic Value
Price
S

See Also

Back to Top